The treatment of xenografted mice with a specific monoclonal VEGFA antibody demonstrated that VEGFA was a strong in vivo pro-angiogenic factor and that its blockade suppressed tumor growth [9]. The gene discussed is VEGFA; the disease is neoplasm.